DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Brexpiprazole
Brexpiprazole
Drug Repurposing for the Management of Depression: Where Do We Stand Currently?
Medication Adherence, Health Care Utilization, and Costs in Patients with Major Depressive Disorder Initiating Adjunctive Atypical * Antipsychotic Treatment
Regulation of Reactive Oxygen Species-Mediated Damage in the Pathogenesis of Schizophrenia
Rexulti (Brexpiprazole)
The Effect of Brexpiprazole (OPC-34712) and Aripiprazole in Adult Patients with Acute Schizophrenia: Results from a Randomized, Exploratory Study
Psychotropic Drug Indications
REXULTI® (Brexpiprazole)
Medications to Be Avoided Or Used with Caution in Parkinson's Disease
Assessment Report
Currently Prescribed Psychotropic Medications
Brexpiprazole (Rexulti)
Evidence-Based Strategies for Achieving Remission and Treating Residual Symptoms in MDD
CLINICAL REVIEW(S) Clinical Review David H
Antipsychotics Therapeutic Class Review (TCR)
Review of Psychotropic Drugs 2009
Rexulti) Reference Number: NE.PMN.68 Effective Date: 01/01/2017 Coding Implications Last Review Date: Revision Log Line of Business: Medicaid
Currently Prescribed Psychotropic Medications
Atypical Antipsychotics Pa Summary
Top View
REXULTI Safely and Effectively
Real-World Economic Outcomes of Brexpiprazole and Extended-Release Quetiapine Adjunctive Use in Major Depressive Disorder
Brexpiprazole (REXULTI®) National Drug Monograph March 2016 VA Pharmacy Benefits Management Services, Medical Advisory Panel, and VISN Pharmacist Executives
1. Title Page Brexpiprazole I: in Vitro and in Vivo Characterization of A
Atypical Antipsychotics
Adjunctive Aripiprazole and Brexpiprazole in the Treatment of Major Depressive Disorder October 2018
RXULTI, INN-Brexpiprazole
Utah Medicaid Dur Report December 2020 Newer Oral
Real-World Economic Outcomes of Brexpiprazole and Extended-Release Quetiapine Adjunctive Use in Major Depressive Disorder
Clinical Policy: Aripiprazole Long-Acting Injections (Abilify
Parenteral Antipsychotics
Cost-Effectiveness of Brexpiprazole Adjunctive Treatment for Major Depressive Disorder
Current Concepts and Treatments of Schizophrenia
Attachment: Extract from Clinical Evaluation: Brexpiprazole
Stopping and Switching Antipsychotic Drugs
Atypical Antipsychotics NOTICE
Strategies for Managing Medication-Induced Hyperprolactinemia
REXULTI Savings Program
Abilify Maintena, Aristada) Reference Number: ERX.SPA.177 Effective Date: 09.05.17 Last Review Date: 11.17 Revision Log
Brexpiprazole (Rexulti) Reference Number: CP.PMN.68 Effective Date: 12.01.15 Last Review Date: 02.20 Line of Business: Commercial, HIM, Medicaid Revision Log
Pharmacological Treatments for Patients with Treatment-Resistant Depression
Patients with a History of Falls and Receiving Tricyclic Antidepressants, Antipsychotics, Or Sleep Agents
A Concise Guide to Monoamine Oxidase Inhibitors: How to Avoid Drug Interactions
Select Antipsychotics Step Therapy • Rexulti (Brexpiprazole)
Clinically Relevant Interactions Between Atypical Antipsychotics and Anti-Infective Agents
Health Care Cost in Patients with Schizophrenia Treated with Brexpiprazole Versus Other Oral Atypical Antipsychotic Therapy*
Simultaneous Determination of Fourteen Antipsychotic Drugs in Whole Blood by Solid Phase Extraction and Liquid Chromatography Tandem Mass Spectrometry
Graylands Hospital Drug Bulletin Brexpiprazole
UPDATE on NEURO/PSYCH MEDICATIONS Steve Williams, Pharm.D
ASHP Therapeutic Position Statement on the Use of Antipsychotic Medications in the Treatment of Adults with Schizophrenia and Schizoaffective Disorder
(REXULTI™) Brexpiprazole
Second-Generation Antipsychotic Tip Sheet
Product Monograph
Brexpiprazole for Schizophrenia and As Adjunct for Major Depressive Disorder
Antipsychotics
Black-Box Warnings for First-Generation Antipsychotics
Mechanism of Action of Atypical Antipsychotic Drugs in Mood Disorders
Antipsychotics Quick Reference Guide (PDF)
Clinical Policy: Brexpiprazole (Rexulti)
Medications to Avoid
Atypical Antipsychotics Comparison Guide
Investigating the Potential Role of Serotonin-2B Receptor Antagonism in the Neuronal Actions of Adjunctive Aripiprazole
Psychopharmacology: the Basics and Beyond
Mechanism of Action of Brexpiprazole: Comparison with Aripiprazole
Multi-Target Approach for Drug Discovery Against Schizophrenia
Antipsychotics for the Prevention and Treatment of Delirium: a Systematic Review